Disease severity and prefrontal cortex activation during obstacle negotiation among patients with Parkinson's disease: Is it all as expected?

被引:1
|
作者
Assad, M. [1 ,2 ]
Galperin, I [1 ,2 ]
Giladi, N. [1 ,3 ,4 ]
Mirelman, A. [1 ,3 ,4 ]
Hausdorff, J. M. [1 ,4 ,5 ,6 ,7 ]
Maidan, I [1 ,3 ,4 ]
机构
[1] Tel Aviv Sourasky Med Ctr, Lab Early Markers Neurodegenerat, Ctr Study Movement Cognit & Mobil, Neurol Inst, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Sch Med, Dept Neurol, Tel Aviv, Israel
[4] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel
[5] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, Tel Aviv, Israel
[6] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL USA
[7] Rush Univ, Med Ctr, Dept Orthopaed Surg, Chicago, IL USA
基金
以色列科学基金会;
关键词
Prefrontal cortex; fNIRS; Obstacle negotiation; Available response time; BRAIN ACTIVATION; COMPLEX WALKING; OLDER-ADULTS; ATTENTION; SIZE;
D O I
10.1016/j.parkreldis.2022.06.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Previous reports indicate that patients with Parkinson's disease (PD) activate the prefrontal cortex (PFC) during complex activities such as obstacle negotiation to compensate for impaired motor function. However, the influence of disease severity on PFC activation has not been systematically evaluated. Here, we examined the effects of disease severity on PFC activation during obstacle negotiation. Methods: 74 patients with PD (age 68.26 +/- 7.54 yrs; 62.2% men) were divided into three groups based on Hoehn and Yahr stages. All patients walked along an obstacle course while negotiating anticipated and unanticipated obstacles (long/low available response time) at heights of 50 mm and 100 mm. PFC activation was measured using functional near-infrared spectroscopy (fNIRS) and was compared between groups and tasks using mixed model analyses. Results: Participants with more advanced PD (i.e., Hoehn & Yahr 3) had higher PFC activation levels when negotiating anticipated obstacles, compared to participants with milder PD (i.e., Hoehn & Yahr 1, 2) (p < 0.001). Moreover, higher LEDD correlated with higher prefrontal activation during the higher anticipated obstacle. In contrast, during the negotiation of unanticipated obstacles, the differences in PFC activation were not associated with disease severity in a linear manner. Conclusions: The present study suggests that with increased disease severity, patients with PD rely more on the PFC when negotiating anticipated obstacles, perhaps to compensate for attention and motor deficits. These findings support the role of cognition in fall risk and the need to improve attention and cognition in fall prevention programs, especially among patients with more advanced disease.
引用
收藏
页码:20 / 26
页数:7
相关论文
共 50 条
  • [1] The effects of obstacle size and timing on prefrontal cortex activation in patients with Parkinson's disease
    Maidan, I.
    Sharon, T.
    Kurz, I.
    Bernad-Elazari, H.
    Shustak, S.
    Galperin, I.
    Giladi, N.
    Mirelman, A.
    Hausdorff, J.
    MOVEMENT DISORDERS, 2019, 34
  • [2] Prefrontal cortex activation during obstacle negotiation: What's the effect size and timing?
    Maidan, Inbal
    Shustak, Shiran
    Sharon, Topaz
    Bernad-Elazari, Hagar
    Geffen, Nimrod
    Giladi, Nir
    Hausdorff, Jeffrey M.
    Mirelman, Anat
    BRAIN AND COGNITION, 2018, 122 : 45 - 51
  • [3] Prefrontal cortex and striatal activation by feedback in Parkinson's disease
    Keitz, Martijn
    Koerts, Janneke
    Kortekaas, Rudie
    Renken, Remco
    de Jong, Bauke M.
    Leenders, Klaus L.
    BRAIN RESEARCH, 2008, 1236 : 225 - 233
  • [4] Prefrontal cortex high beta power correlates with the severity of anxiety and depression in Parkinson's disease patients
    de Hemptinne, C.
    Chen, W.
    Racine, C.
    Seritan, A.
    Mergenthaler, J.
    Rajagopalan, S.
    Ostrem, J.
    Starr, P.
    MOVEMENT DISORDERS, 2019, 34
  • [5] Disease severity affects obstacle crossing in people with Parkinson's disease
    Vitorio, Rodrigo
    Lirani-Silva, Ellen
    Baptista, Andre Macari
    Barbieri, Fabio Augusto
    Rocha dos Santos, Paulo Cezar
    Teixeira-Arroyo, Claudia
    Bucken Gobbi, Lilian Teresa
    GAIT & POSTURE, 2014, 40 (01) : 266 - 269
  • [6] Levodopa Facilitates Prefrontal Cortex Activation During Dual Task Walking in Parkinson Disease
    Orcioli-Silva, Diego
    Vitorio, Rodrigo
    Nobrega-Sousa, Priscila
    da Conceicao, Nubia Ribeiro
    Beretta, Victor Spiandor
    Lirani-Silva, Ellen
    Gobbi, Lilian Teresa Bucken
    NEUROREHABILITATION AND NEURAL REPAIR, 2020, 34 (07) : 589 - 599
  • [7] microRNA Profiles in Parkinson's Disease Prefrontal Cortex
    Hoss, Andrew G.
    Labadorf, Adam
    Beach, Thomas G.
    Latourelle, Jeanne C.
    Myers, Richard H.
    FRONTIERS IN AGING NEUROSCIENCE, 2016, 8
  • [8] The Metabolic Activity of Caudate and Prefrontal Cortex Negatively Correlates with the Severity of Idiopathic Parkinson's Disease
    Chu, Jun-Sheng
    Liu, Ting-Hong
    Wang, Kai-Liang
    Han, Chun-Lei
    Liu, Yun-Peng
    Michitomo, Shimabukuro
    Zhang, Jian-Guo
    Fang, Tie
    Meng, Fan-Gang
    AGING AND DISEASE, 2019, 10 (04): : 847 - 853
  • [9] ALTERED DLPFC ACTIVATION DURING GAIT AMONG PATIENTS WITH PARKINSON'S DISEASE
    Mirelman, A.
    GERONTOLOGIST, 2016, 56 : 453 - 453
  • [10] Obstacle stepping in patients with Parkinson's disease
    Michel, Jan
    Benninger, David
    Dietz, Volker
    van Hedel, Hubertus J. A.
    JOURNAL OF NEUROLOGY, 2009, 256 (03) : 457 - 463